D. E. Shaw & Co., Inc. Bio Xcel Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.32 - $5.51 $98,272 - $233,398	42,359 New	42,359 $124,000
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $713,119 - $1.23 Million	-19,047 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $335,608 - $1.12 Million	19,047 New	19,047 $1.01 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.